Health
Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition – News-Medical.net
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma….
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled…
-
Noosa News23 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General23 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General23 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
General18 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate